MM-019

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMM-019
Drug Alias NameAnQlarGCPQNM-MMTMM-019MMS-019
ClassificationOther
Mechanisms of ActionVirus replication inhibitorsVirus internalization inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanomerics LtdVirpax Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeqensSinclair ResearchVirpax Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A